Organon , a global independent healthcare company with a focus on women's health, will present results from a sub-analysis of pooled data from the Phase 3 ADORING 1 and ADORING 2 pivotal trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback